Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News EuroPCR 2023

AnchorMan LAAO Device Matches Up Well With the Watchman

Todd Neale

May 19, 2023

News Conference News EuroPCR 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Todd Neale

May 18, 2023

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Caitlin E. Cox

May 31, 2019

Presentation EuroPCR 2019

Leaflet edge-to-edge treatment versus direct annuloplasty in patients with functional mitral regurgitation

Presenter: Marcel Weber

May 21, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

News Conference News EuroPCR 2016

LAA Closure May Provide Solution for Stroke Prevention in Patients With Prior Intracerebral Hemorrhage

Yael L. Maxwell

May 18, 2016

Presentation EuroPCR 2016

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Presenter: Martin Bergmann

May 18, 2016

News Conference News EuroPCR 2016

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Yael L. Maxwell

May 17, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

Presentation EuroPCR 2014

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

Presenter: Josep Rod?s-Cabau

May 20, 2014

Advertisement

AnchorMan LAAO Device Matches Up Well With the Watchman

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Leaflet edge-to-edge treatment versus direct annuloplasty in patients with functional mitral regurgitation

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

LAA Closure May Provide Solution for Stroke Prevention in Patients With Prior Intracerebral Hemorrhage

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Benefit of LAA Closure Becomes Most Evident After 1 Year

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content